Next-Gen Baby Box Award Winner adds American Technology to a Finnish tradition
CONCORD, MA - July 2, 2019 - Today Prapela, Inc. announced its full release of the Prapela SVS baby box to help console irritable newborns in a safe sleep environment. Prapela's baby box features SVS a gentle, random vibration proven in clinical studies with both preemies and substance-exposed newborns. SVS operates with one proven setting, is non-habit forming, and does not interrupt sleep cycles.
The SVS baby box was initially recognized by Johnson & Johnson and the Finnish Innovation Fund after winning the Next-Gen QuickFire Challenge on December 4, 2017. Since then, Prapela licensed intellectual property from Harvard's Office of Technology Development improved quality and reduced the cost of the SVS sleep pad. "After more than 2 years at Prapela and another 10 years in development at the University of Massachusetts Medical Center, Harvard's Wyss Institute for Biologically Inspired Engineering and the Mass General Hospital, we are excited to make this solution available," said John Konsin, Co-founder and CEO of Prapela, Inc.
Initially, the company is hoping to help substance-exposed newborns after they have been discharged from a hospital. At home, substance-exposed babies continue to be hyperirritable requiring near-constant snuggling and soothing, which can exhaust caregivers and increase the risk for unsafe sleep. "While many States and organizations provide baby boxes to reduce the risk of infant sleep mortality, the Prapela SVS baby box is the first baby box that promotes infant relaxation and safe sleep helping caregivers get the rest they deserve," said Konsin.
Made in America with domestic and carefully selected imported parts, the product sells for $234 with free shipping exclusively at www.prapela.com.